These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J2806

  Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms

• J2810

  Injection, theophylline, per 40 mg

• J2820

  Injection, sargramostim (gm-csf), 50 mcg

• J2840

  Injection, sebelipase alfa, 1 mg

• J2850

  Injection, secretin, synthetic, human, 1 microgram

• J2860

  Injection, siltuximab, 10 mg

• J2865

  Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg

• J2910

  Injection, aurothioglucose, up to 50 mg

• J2916

  Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg

• J2919

  Injection, methylprednisolone sodium succinate, 5 mg

• J2920

  Injection, methylprednisolone sodium succinate, up to 40 mg

• J2930

  Injection, methylprednisolone sodium succinate, up to 125 mg

• J2940

  Injection, somatrem, 1 mg

• J2941

  Injection, somatropin, 1 mg

• J2950

  Injection, promazine hcl, up to 25 mg

• J2993

  Injection, reteplase, 18.1 mg

• J2995

  Injection, streptokinase, per 250,000 iu

• J2997

  Injection, alteplase recombinant, 1 mg

• J2998

  Injection, plasminogen, human-tvmh, 1 mg

• J3000

  Injection, streptomycin, up to 1 gm

• J3010

  Injection, fentanyl citrate, 0.1 mg

• J3030

  Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

• J3031

  Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)

• J3032

  Injection, eptinezumab-jjmr, 1 mg

• J3055

  Injection, talquetamab-tgvs, 0.25 mg

• J3060

  Injection, taliglucerase alfa, 10 units

• J3070

  Injection, pentazocine, 30 mg

• J3090

  Injection, tedizolid phosphate, 1 mg

• J3095

  Injection, telavancin, 10 mg

• J3101

  Injection, tenecteplase, 1 mg

• J3105

  Injection, terbutaline sulfate, up to 1 mg

• J3110

  Injection, teriparatide, 10 mcg

• J3111

  Injection, romosozumab-aqqg, 1 mg

• J3120

  Injection, testosterone enanthate, up to 100 mg

• J3121

  Injection, testosterone enanthate, 1 mg

• J3130

  Injection, testosterone enanthate, up to 200 mg

• J3140

  Injection, testosterone suspension, up to 50 mg

• J3145

  Injection, testosterone undecanoate, 1 mg

• J3150

  Injection, testosterone propionate, up to 100 mg

• J3230

  Injection, chlorpromazine hcl, up to 50 mg

• J3240

  Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial

• J3241

  Injection, teprotumumab-trbw, 10 mg

• J3243

  Injection, tigecycline, 1 mg

• J3244

  Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg

• J3245

  Injection, tildrakizumab, 1 mg

• J3246

  Injection, tirofiban hcl, 0.25 mg

• J3247

  Injection, secukinumab, intravenous, 1 mg

• J3250

  Injection, trimethobenzamide hcl, up to 200 mg

• J3260

  Injection, tobramycin sulfate, up to 80 mg

• J3262

  Injection, tocilizumab, 1 mg

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.